Related Experiment Video
Updated: Mar 29, 2026
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
[Clostridium difficile associated diarrhea in children]
Insights
Clostridium difficile infections (CDI) are a growing concern in healthcare settings and the community. Early diagnosis and appropriate management are crucial for improving outcomes in pediatric patients.
Area of Science:
- Microbiology
- Infectious Diseases
- Pediatrics
Background:
- Clostridium difficile is a leading cause of antimicrobial-associated diarrhea and is increasingly relevant in community-acquired infections.
- It is a Gram-positive bacillus transmitted via the fecal-oral route, posing risks in both community and hospital settings.
- While asymptomatic colonization is common, risk factors in children include antibiotic exposure, hospitalization, and immunosuppression.
Purpose of the Study:
- To review the epidemiology, diagnosis, management, and prevention of Clostridium difficile infections in pediatric patients.
- To highlight the increasing incidence, morbidity, and mortality associated with C. difficile.
Main Methods:
- Diagnosis relies on clinical criteria and laboratory confirmation with high sensitivity and specificity.
- Pediatric diagnostic recommendations vary by age, with specific guidelines from the American Academy of Pediatrics (AAP).
Main Results:
- Clostridium difficile infection (CDI) can range from asymptomatic colonization to severe, fulminant disease.
- Management strategies include antimicrobial suspension for mild to moderate cases and vancomycin or metronidazole for severe cases, typically over 10 days.
Conclusions:
- Antimicrobial stewardship programs and stringent environmental controls are key preventive measures.
- Further research is needed to understand and combat the rising complexity and impact of C. difficile in pediatric populations.
Introduction:
Clostridium difficile is the most commonly isolated organism in antimicrobial and health care-associated diarrhea and is growing in relevance in community-acquired infections. It is a Gram-positive bacillus acquired via the fecal-oral route in the community and in hospital setting.
Epidemiology:
0.6 to 2.1% worldwide incidence, mortality ~ 1-5%. COLONIZATION: High rates of asymptomatic colonization in healthy people, 37% in children: its presence in stools is of controversial significance. Risk factors in children are prior exposure to antibiotics, recent hospitalization, immunosuppression or inflammatory bowel disease.
Clinical Manifestations:
Secondary to intestinal involvement due to toxin production, ranging from asymptomatic colonization to fulminant disease.
Diagnosis:
Clinical diagnostic criteria plus high sensitivity and specificity laboratory certification. Recommendations AAP (American Academy of Pediatrics): under 1 year, avoid routine study, only in Hirschsprung disease and/or nosocomial outbreak, 1-3 year, a (+) result suggests C. difficile associated diarrhea (CDAD) is possible, and in children older than 3 years interpretation is equal to adults.
Management:
Antimicrobial suspension, oral metronidazole as first line in mild to moderate CDAD, and oral or enema vancomycin or associated with intravenous metronidazole only in severe cases. Duration 10 days.
Prevention:
Antimicrobial control programs and environmental management.
Conclusion:
Given the increasing complexity of pediatric patients it is important to deepen the knowledge on this microorganism and its clinical manifestations, as its incidence, morbidity and mortality are increasing.
Related Concept Videos
01:18Bacterial Gastroenteritis
01:18Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:25Immunodeficiency Diseases
There are three main causes of immunodeficiency...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:28Diphtheria